AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 717, 21st Century Cancer ALERT Act - discussions of draft language S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors, met with OPM for FEHBP coverage of clinical trials H.R. 1844, Comprehensive Cancer Care Improvement Act, discussions of draft language; seeking cosponsors H.R.2109, Childhood Cancer Survivorship Research and Quality of Life Act, discussions of draft language, seeking cosponsors
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Medicare/Medicaid MMM
H.R. 1392, To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program, seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, general discussions on drafting of the legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Budget/Appropriations BUD
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.